BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15863033)

  • 21. Extracellular interactome of the FGF receptor-ligand system: complexities and the relative simplicity of the worm.
    Polanska UM; Fernig DG; Kinnunen T
    Dev Dyn; 2009 Feb; 238(2):277-93. PubMed ID: 18985724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF signaling in prostate tumorigenesis--new insights into epithelial-stromal interactions.
    Abate-Shen C; Shen MM
    Cancer Cell; 2007 Dec; 12(6):495-7. PubMed ID: 18068626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling.
    Friesel R; Maciag T
    Thromb Haemost; 1999 Aug; 82(2):748-54. PubMed ID: 10605778
    [No Abstract]   [Full Text] [Related]  

  • 24. Fibroblast growth factor signaling in embryonic and cancer stem cells.
    Dvorak P; Dvorakova D; Hampl A
    FEBS Lett; 2006 May; 580(12):2869-74. PubMed ID: 16516203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling.
    Kovalenko D; Yang X; Chen PY; Nadeau RJ; Zubanova O; Pigeon K; Friesel R
    Cell Signal; 2006 Nov; 18(11):1958-66. PubMed ID: 16603339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF signaling network in the gastrointestinal tract (review).
    Katoh M; Katoh M
    Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction: fibroblast growth factors and their receptors in development and disease.
    Nilsen-Hamilton M
    Mol Reprod Dev; 1994 Sep; 39(1):41-2. PubMed ID: 7999361
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibroblast growth factor signaling during early vertebrate development.
    Böttcher RT; Niehrs C
    Endocr Rev; 2005 Feb; 26(1):63-77. PubMed ID: 15689573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of specific FGF ligands and receptor isoforms during osteogenic differentiation of mouse Adipose-derived Stem Cells (mASCs) recapitulates the in vivo osteogenic pattern.
    Quarto N; Longaker MT
    Gene; 2008 Nov; 424(1-2):130-40. PubMed ID: 18718860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of Sef, an inhibitor of receptor tyrosine kinase signaling, is common to a variety of human carcinomas.
    Zisman-Rozen S; Fink D; Ben-Izhak O; Fuchs Y; Brodski A; Kraus MH; Bejar J; Ron D
    Oncogene; 2007 Sep; 26(41):6093-8. PubMed ID: 17420726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines.
    Tomlinson DC; L'Hôte CG; Kennedy W; Pitt E; Knowles MA
    Cancer Res; 2005 Nov; 65(22):10441-9. PubMed ID: 16288035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SRC-3/AIB1: transcriptional coactivator in oncogenesis.
    Yan J; Tsai SY; Tsai MJ
    Acta Pharmacol Sin; 2006 Apr; 27(4):387-94. PubMed ID: 16539836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of fibroblast growth factor 8 in growth and progression of hormonal cancer.
    Mattila MM; Härkönen PL
    Cytokine Growth Factor Rev; 2007; 18(3-4):257-66. PubMed ID: 17512240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WNT signaling pathway and stem cell signaling network.
    Katoh M; Katoh M
    Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
    Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evolutionary history of the FGF superfamily.
    Popovici C; Roubin R; Coulier F; Birnbaum D
    Bioessays; 2005 Aug; 27(8):849-57. PubMed ID: 16015590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
    Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
    J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGF and FGFR signaling in chondrodysplasias and craniosynostosis.
    Marie PJ; Coffin JD; Hurley MM
    J Cell Biochem; 2005 Dec; 96(5):888-96. PubMed ID: 16149058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.